Metabolomic predictor

National Cancer InstituteUS$1.9mNational Institute of Diabetes and Digestive and Kidney DiseasesUS$1.9m

• Metabolomic predictors of insulin resistance and diabetes

  National Institute of Diabetes and Digestive and Kidney DiseasesBeth Israel Deaconess Medical CenterUS$649k2008–2027

• Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer

  National Cancer InstituteIndiana University IndianapolisUS$661.4k2021–2027